Autopsy report · NCT00207025
A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
Cause of deathNo reason given
Life of this trial
- Registered 11 months after it had already started.
- 60 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Bristol-Myers Squibb
- Sponsor type
- Industry
- Conditions
- Tumors
- Interventions
- BMS-275183
- Participants
- 60
- Sites
- 3
- Countries
- Belgium, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.